{
    "id": 10465,
    "fullName": "ATR mutant",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "ATR mutant indicates an unspecified mutation in the ATR gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 545,
        "geneSymbol": "ATR",
        "terms": [
            "ATR",
            "FCTCS",
            "FRP1",
            "MEC1",
            "SCKL",
            "SCKL1"
        ]
    },
    "variant": "mutant",
    "createDate": "08/10/2015",
    "updateDate": "12/14/2015",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10456,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, the combination of Afinitor (everolimus) and Taxol (paclitaxel) resulted in a partial response lasting over 13 months in a metastatic urothelial carcinoma patient harboring NF2 Y153fs*1, as well as ATM V2119fs*8, an ATR splice site mutation, and TP53 R280K, who had progressed on platinum-based chemotherapy and single agent Taxotere (docetaxel) therapy (PMID: 25630452).",
            "molecularProfile": {
                "id": 27471,
                "profileName": "ATM V2119fs ATR mut NF2 Y153fs TP53 R280K"
            },
            "therapy": {
                "id": 5505,
                "therapyName": "Everolimus + Paclitaxel",
                "synonyms": null
            },
            "indication": {
                "id": 2671,
                "name": "transitional cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 8466,
                    "pubMedId": 25630452,
                    "title": "Exceptional Response on Addition of Everolimus to Taxane in Urothelial Carcinoma Bearing an NF2 Mutation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25630452"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 10468,
            "profileName": "ATR mutant",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 27471,
            "profileName": "ATM V2119fs ATR mut NF2 Y153fs TP53 R280K",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}